Cargando…
Drugging the addict: non‐oncogene addiction as a target for cancer therapy
Historically, cancers have been treated with chemotherapeutics aimed to have profound effects on tumor cells with only limited effects on normal tissue. This approach was followed by the development of small‐molecule inhibitors that can target oncogenic pathways critical for the survival of tumor ce...
Autores principales: | Nagel, Remco, Semenova, Ekaterina A, Berns, Anton |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5090709/ https://www.ncbi.nlm.nih.gov/pubmed/27702988 http://dx.doi.org/10.15252/embr.201643030 |
Ejemplares similares
-
Targeting Non-Oncogene Addiction for Cancer Therapy
por: Chang, Hae Ryung, et al.
Publicado: (2021) -
Origins, genetic landscape, and emerging therapies of small cell lung cancer
por: Semenova, Ekaterina A., et al.
Publicado: (2015) -
Targeting of non-oncogene addiction
por: Igea, Ana, et al.
Publicado: (2015) -
Targeting Non-Oncogene Addiction: Focus on Thyroid Cancer
por: Anania, Maria Chiara, et al.
Publicado: (2020) -
Oncogene addiction in gliomas: Implications for molecular targeted therapy
por: Yan, Wei, et al.
Publicado: (2011)